Compare SON & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SON | BLLN |
|---|---|---|
| Founded | 1899 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.6B |
| IPO Year | 2014 | 2025 |
| Metric | SON | BLLN |
|---|---|---|
| Price | $57.14 | $89.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $60.13 | ★ $126.71 |
| AVG Volume (30 Days) | ★ 1.1M | 779.6K |
| Earning Date | 04-21-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | ★ 510.30 | 103.40 |
| EPS | ★ 0.68 | 0.48 |
| Revenue | ★ $7,518,753,000.00 | $305,112,000.00 |
| Revenue This Year | $0.10 | $46.29 |
| Revenue Next Year | $1.82 | $30.14 |
| P/E Ratio | ★ $83.46 | $195.65 |
| Revenue Growth | 41.72 | ★ 99.97 |
| 52 Week Low | $38.65 | $61.96 |
| 52 Week High | $60.67 | $150.44 |
| Indicator | SON | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 33.40 |
| Support Level | $55.38 | $83.59 |
| Resistance Level | $58.08 | $99.29 |
| Average True Range (ATR) | 1.40 | 6.68 |
| MACD | -0.24 | -4.24 |
| Stochastic Oscillator | 47.95 | 1.13 |
Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.